Exchange: NYSEMkt·Updated 04:10 PM EST
SER logo

SER Serina Therapeutics Inc.

$1.12
$0.08
(6.67%)
Today
Closed $1.12
$0.00
(0.00%)
After Hours
Mkt Cap$31.88M
Vol62,151.00

About SER

Serina Therapeutics, Inc. operates as a clinical-stage biotechnology company, which engages in the research and development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley in 2006 and is headquartered in Huntsville, AL.
53

Neutral Sentiment

How do you feel about SER?

Rayvio_News_Filter
$SER 🏥 Serina Therapeutics initiated dosing in Cohort 2 of the registrational study of SER-252 in Parkinson's disease after an independent safety monitoring committee recommended advancement. Curated for market relevance
2

Advertisement|Remove ads.